Research Areas
Dr. Zhang's work focuses on developing nanomaterials for the delivery of a wide variety of drugs to metastatic cancer cells in the circulation. One such therapeutic Jason interfaces with is Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL), and he works to package soluble TRAIL in a variety of nano carriers as well as work on fusogenic liposomes with TRAIL as the delivered drug to avoid endocytosis and endosomal encapsulation.
